Regeneron Pharmaceuticals (REGN) Cash & Current Investments (2009 - 2026)
Regeneron Pharmaceuticals' Cash & Current Investments came in at $7.99 billion for Q2 2026, up 7.0% from $7.47 billion a year earlier but down 8.7% from the prior quarter.
Powered by 
Analysis
Regeneron Pharmaceuticals (REGN) Cash & Current Investments (2009 - 2026) Analysis & Trends
At the end of FY2025, Regeneron Pharmaceuticals' Cash & Current Investments was $8.61 billion, down 4.5% from FY2024.
- Cash & Current Investments carries a five-year compound annual growth rate of 19.1% (FY2020 to FY2025).
- Going back by year, Cash & Current Investments was $9.01 billion in FY2024 (-16.9%), $10.84 billion in FY2023 (+40.1%), $7.74 billion in FY2022 (+36.0%) and $5.69 billion in FY2021 (+58.8%).
- The five-year range for quarterly Cash & Current Investments is $5.69 billion (Q4 2021) to $10.84 billion (Q4 2023).
- Year-over-year, Cash & Current Investments increased in two of the last eight quarters, with an average decline of 8.6%.
- The fastest year-over-year change in Cash & Current Investments over five years came in Q1 2022 (growth of 101.2%), and the weakest in Q2 2025 (a decline of 23.8%).
- Business Quant data shows REGN's Cash & Current Investments at $8.75 billion (Q1 2026), $8.61 billion (Q4 2025) and $8.44 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn | 20.76 Bn |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn | 7.69 Bn |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn | 11.70 Bn |
| 10 | Regeneron Pharmaceuticals | 81.27 Bn | 47.47 Bn | 3.71 Bn | 7.99 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.99 Bn |
| Mar 31, 2026 | 8.75 Bn |
| Dec 31, 2025 | 8.61 Bn |
| Sep 30, 2025 | 8.44 Bn |
| Jun 30, 2025 | 7.47 Bn |
| Mar 31, 2025 | 8.35 Bn |
| Dec 31, 2024 | 9.01 Bn |
| Sep 30, 2024 | 9.80 Bn |
| Jun 30, 2024 | 9.81 Bn |
| Mar 31, 2024 | 10.52 Bn |
| Dec 31, 2023 | 10.84 Bn |
| Sep 30, 2023 | 9.91 Bn |
| Jun 30, 2023 | 8.93 Bn |
| Mar 31, 2023 | 8.96 Bn |
| Dec 31, 2022 | 7.74 Bn |
| Sep 30, 2022 | 7.02 Bn |
| Jun 30, 2022 | 7.57 Bn |
| Mar 31, 2022 | 7.05 Bn |
| Dec 31, 2021 | 5.69 Bn |
| Sep 30, 2021 | 5.79 Bn |
API Access
Regeneron Pharmaceuticals Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=REGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "REGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=REGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();